| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.721 | 0.021 | 0.721 | Caspase 9 stimulant | 0.278 0.219 CID_154700105 | ||
| 0.606 | 0.018 | 0.606 | Aldehyde oxidase inhibitor | 0.147 0.142 CID_154700105 | ||
| 0.589 | 0.005 | 0.589 | Topoisomerase II inhibitor | 0.239 0.026 CID_154700105 | ||
| 0.561 | 0.004 | 0.561 | Alpha-N-acetylglucosaminidase inhibitor | 0.177 0.042 CID_154700105 | ||
| 0.533 | 0.004 | 0.533 | Topoisomerase II alpha inhibitor | 0.16 0.021 CID_154700105 | ||
| 0.513 | 0.022 | 0.513 | GABA C receptor rho-3 antagonist | 0.265 0.142 CID_154700105 | ||
| 0.508 | 0.03 | 0.508 | 5 Hydroxytryptamine release inhibitor | 0.247 0.233 CID_154700105 | ||
| 0.5 | 0.029 | 0.51 | Histamine release inhibitor | 0.51 0.025 CID_154700105 | CID_154700105 | |
| 0.466 | 0.004 | 0.736 | NMDA 2B receptor antagonist | 0.736 0.002 CID_154700105 | CID_154700105 | |
| 0.496 | 0.075 | 0.496 | Apoptosis agonist | 0.315 0.162 CID_154700105 | ||
| 0.432 | 0.022 | 0.432 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.404 | 0.007 | 0.404 | DNA intercalator | 0.281 0.013 CID_154700105 | ||
| 0.414 | 0.019 | 0.414 | Peroxidase inhibitor | 0.234 0.051 CID_154700105 | ||
| 0.422 | 0.038 | 0.422 | Caspase 3 stimulant | |||
| 0.444 | 0.065 | 0.444 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.294 0.221 CID_154700105 | ||
| 0.416 | 0.043 | 0.416 | 5 Hydroxytryptamine release stimulant | |||
| 0.395 | 0.029 | 0.395 | HERG channel blocker | |||
| 0.376 | 0.035 | 0.376 | Calcium channel activator | 0.267 0.128 CID_154700105 | ||
| 0.353 | 0.012 | 0.353 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.343 | 0.007 | 0.343 | Cystathionine beta-synthase inhibitor | 0.119 0.059 CID_154700105 | ||
| 0.361 | 0.028 | 0.361 | DNA synthesis inhibitor | 0.25 0.066 CID_154700105 | ||
| 0.344 | 0.012 | 0.344 | NOS3 expression enhancer | 0.177 0.052 CID_154700105 | ||
| 0.375 | 0.046 | 0.375 | Spasmolytic | 0.27 0.083 CID_154700105 | ||
| 0.337 | 0.008 | 0.337 | Topoisomerase I inhibitor | 0.2 0.026 CID_154700105 | ||
| 0.338 | 0.01 | 0.338 | Neurotrophic factor enhancer | 0.152 0.134 CID_154700105 | ||
| 0.351 | 0.025 | 0.351 | 5 Hydroxytryptamine uptake stimulant | 0.205 0.143 CID_154700105 | ||
| 0.331 | 0.005 | 0.331 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.361 | 0.038 | 0.361 | DNA damaging | 0.196 0.119 CID_154700105 | ||
| 0.331 | 0.021 | 0.331 | Tyrosine 3 hydroxylase inhibitor | 0.204 0.129 CID_154700105 | ||
| 0.346 | 0.037 | 0.548 | Superoxide dismutase inhibitor | 0.548 0.009 CID_154700105 | CID_154700105 | |
| 0.335 | 0.036 | 0.335 | Antimitotic | |||
| 0.308 | 0.01 | 0.308 | UDP-glucose 4-epimerase inhibitor | 0.091 0.072 CID_154700105 | ||
| 0.344 | 0.047 | 0.344 | Hypoxia-inducible factor 1 alpha inhibitor | 0.223 0.126 CID_154700105 | ||
| 0.31 | 0.03 | 0.5 | RNA-directed DNA polymerase inhibitor | 0.5 0.011 CID_154700105 | CID_154700105 | |
| 0.36 | 0.081 | 0.395 | Immunosuppressant | 0.395 0.065 CID_154700105 | CID_154700105 | |
| 0.35 | 0.074 | 0.35 | Vasodilator, peripheral | |||
| 0.372 | 0.101 | 0.372 | Calcium channel L-type activator | |||
| 0.34 | 0.068 | 0.608 | Cholesterol antagonist | 0.608 0.018 CID_154700105 | CID_154700105 | |
| 0.31 | 0.038 | 0.31 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.265 | 0.005 | 0.265 | Alcohol oxidase inhibitor | |||
| 0.267 | 0.01 | 0.267 | ATPase inhibitor | |||
| 0.268 | 0.015 | 0.268 | Alkylator | 0.208 0.024 CID_154700105 | ||
| 0.257 | 0.005 | 0.257 | MAP3K9 inhibitor | 0.181 0.026 CID_154700105 | ||
| 0.254 | 0.005 | 0.254 | Photosensitizer | 0.166 0.023 CID_154700105 | ||
| 0.314 | 0.067 | 0.314 | Sodium/bile acid cotransporter inhibitor | 0.252 0.126 CID_154700105 | ||
| 0.283 | 0.037 | 0.283 | Anesthetic general | |||
| 0.326 | 0.084 | 0.326 | Transcription factor NF kappa B inhibitor | 0.288 0.101 CID_154700105 | ||
| 0.262 | 0.024 | 0.262 | Tubulin antagonist | |||
| 0.253 | 0.016 | 0.253 | Hexokinase inhibitor | 0.13 0.104 CID_154700105 | ||
| 0.241 | 0.014 | 0.241 | GABA C receptor agonist | |||
| 0.277 | 0.051 | 0.277 | Gastrin inhibitor | 0.196 0.156 CID_154700105 | ||
| 0.231 | 0.008 | 0.418 | Triose-phosphate isomerase inhibitor | 0.418 0.003 CID_154700105 | CID_154700105 | |
| 0.239 | 0.019 | 0.239 | DNA polymerase I inhibitor | 0.112 0.075 CID_154700105 | ||
| 0.333 | 0.112 | 0.523 | Antibacterial | 0.523 0.034 CID_154700105 | CID_154700105 | |
| 0.275 | 0.055 | 0.275 | Potassium channel blocker | |||
| 0.25 | 0.032 | 0.25 | Nitric-oxide synthase stimulant | |||
| 0.23 | 0.012 | 0.23 | Adenylate kinase inhibitor | 0.138 0.032 CID_154700105 | ||
| 0.224 | 0.01 | 0.224 | Estrogen antagonist | |||
| 0.272 | 0.058 | 0.272 | Hypolipemic | |||
| 0.225 | 0.012 | 0.225 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.331 | 0.12 | 0.331 | Analgesic | |||
| 0.213 | 0.006 | 0.213 | Phenylalanine 4-hydroxylase inhibitor | 0.12 0.018 CID_154700105 | ||
| 0.216 | 0.008 | 0.216 | Creatine kinase inhibitor | 0.13 0.034 CID_154700105 | ||
| 0.215 | 0.009 | 0.215 | Estrogen receptor beta antagonist | 0.099 0.066 CID_154700105 | ||
| 0.232 | 0.029 | 0.341 | Phospholipase C inhibitor | 0.341 0.015 CID_154700105 | CID_154700105 | |
| 0.232 | 0.029 | 0.232 | Succinate dehydrogenase inhibitor | 0.187 0.06 CID_154700105 | ||
| 0.209 | 0.007 | 0.209 | Beta tubulin antagonist | |||
| 0.218 | 0.018 | 0.218 | Arachidonic acid antagonist | 0.164 0.072 CID_154700105 | ||
| 0.207 | 0.01 | 0.207 | NADH dehydrogenase inhibitor | 0.125 0.026 CID_154700105 | ||
| 0.212 | 0.016 | 0.212 | CF transmembrane conductance regulator agonist | |||
| 0.204 | 0.012 | 0.217 | Adenylate cyclase stimulant | 0.217 0.008 CID_154700105 | CID_154700105 | |
| 0.237 | 0.047 | 0.237 | Growth hormone agonist | |||
| 0.212 | 0.025 | 0.212 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.208 | 0.023 | 0.226 | Glutamate receptor antagonist | 0.226 0.019 CID_154700105 | CID_154700105 | |
| 0.195 | 0.013 | 0.195 | HIV-1 integrase (Overall Integration) inhibitor | 0.155 0.024 CID_154700105 | ||
| 0.201 | 0.019 | 0.201 | Microtubule formation inhibitor | |||
| 0.217 | 0.035 | 0.217 | Melanin inhibitor | |||
| 0.186 | 0.005 | 0.186 | Ca2+-transporting ATPase inhibitor | 0.142 0.065 CID_154700105 | ||
| 0.256 | 0.076 | 0.256 | Aryl hydrocarbon receptor agonist | |||
| 0.257 | 0.08 | 0.381 | Antioxidant | 0.381 0.038 CID_154700105 | CID_154700105 | |
| 0.214 | 0.039 | 0.214 | Amylase inhibitor | |||
| 0.252 | 0.077 | 0.252 | Interleukin agonist | |||
| 0.197 | 0.023 | 0.197 | Ferrochelatase inhibitor | |||
| 0.191 | 0.018 | 0.191 | MAP kinase kinase 4 inhibitor | |||
| 0.192 | 0.023 | 0.192 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.198 | 0.03 | 0.198 | GABA C receptor rho-2 antagonist | |||
| 0.19 | 0.023 | 0.19 | Antineoplastic antibiotic | 0.119 0.039 CID_154700105 | ||
| 0.195 | 0.029 | 0.195 | Aldehyde dehydrogenase inhibitor | |||
| 0.177 | 0.014 | 0.177 | Phosphofructokinase-1 inhibitor | 0.092 0.035 CID_154700105 | ||
| 0.176 | 0.015 | 0.176 | DNA repair enzyme inhibitor | 0.13 0.055 CID_154700105 | ||
| 0.18 | 0.019 | 0.18 | Protein kinase C gamma inhibitor | |||
| 0.188 | 0.028 | 0.188 | Adenylate cyclase inhibitor | |||
| 0.166 | 0.007 | 0.166 | Glutamate release inhibitor | |||
| 0.165 | 0.008 | 0.165 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.252 | 0.099 | 0.252 | Lipoxygenase inhibitor | |||
| 0.162 | 0.01 | 0.162 | Estrogen receptor alpha antagonist | 0.072 0.064 CID_154700105 | ||
| 0.268 | 0.117 | 0.268 | Vasodilator, coronary | |||
| 0.157 | 0.008 | 0.157 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.05 0.049 CID_154700105 | ||
| 0.222 | 0.074 | 0.222 | Peptidyltransferase inhibitor | |||
| 0.168 | 0.022 | 0.168 | GABA C receptor antagonist | 0.157 0.026 CID_154700105 | ||
| 0.16 | 0.016 | 0.16 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.08 0.051 CID_154700105 | ||
| 0.166 | 0.023 | 0.166 | Antineoplastic alkaloid | |||
| 0.157 | 0.015 | 0.437 | NMDA 2 receptor antagonist | 0.437 0.004 CID_154700105 | CID_154700105 | |
| 0.156 | 0.015 | 0.181 | Anabolic | 0.181 0.007 CID_154700105 | CID_154700105 | |
| 0.23 | 0.089 | 0.23 | Hypoglycemic | |||
| 0.149 | 0.009 | 0.149 | Biliverdin reductase inhibitor | |||
| 0.203 | 0.066 | 0.203 | Nitric oxide antagonist | |||
| 0.162 | 0.025 | 0.162 | Heat shock protein 70 antagonist | |||
| 0.196 | 0.059 | 0.196 | Lipocortins synthesis antagonist | |||
| 0.147 | 0.012 | 0.147 | Carbamoyl phosphate synthetase inhibitor | 0.085 0.026 CID_154700105 | ||
| 0.147 | 0.012 | 0.341 | Estrogen agonist | 0.341 0.005 CID_154700105 | CID_154700105 | |
| 0.156 | 0.022 | 0.156 | Sphingomyelinase inhibitor | |||
| 0.156 | 0.023 | 0.313 | NMDA receptor antagonist | 0.313 0.006 CID_154700105 | CID_154700105 | |
| 0.166 | 0.037 | 0.295 | Cholesterol synthesis inhibitor | 0.295 0.012 CID_154700105 | CID_154700105 | |
| 0.139 | 0.01 | 0.139 | ATPase (Vacuolar H+) inhibitor | |||
| 0.149 | 0.02 | 0.414 | Protein kinase C zeta inhibitor | 0.414 0.004 CID_154700105 | CID_154700105 | |
| 0.138 | 0.01 | 0.226 | Glycine receptor antagonist | 0.226 0.003 CID_154700105 | CID_154700105 | |
| 0.149 | 0.022 | 0.149 | GABA C receptor rho-1 antagonist | |||
| 0.134 | 0.009 | 0.134 | Glycine receptor agonist | 0.078 0.042 CID_154700105 | ||
| 0.145 | 0.022 | 0.145 | Alcohol dehydrogenase inhibitor | |||
| 0.246 | 0.124 | 0.246 | Interleukin 2 agonist | |||
| 0.175 | 0.053 | 0.175 | Protein kinase stimulant | |||
| 0.175 | 0.054 | 0.175 | Interferon gamma antagonist | |||
| 0.173 | 0.053 | 0.173 | Heat shock protein 90 antagonist | |||
| 0.226 | 0.106 | 0.398 | Immunostimulant | 0.398 0.05 CID_154700105 | CID_154700105 | |
| 0.138 | 0.018 | 0.138 | Glutamate dehydrogenase inhibitor | 0.08 0.045 CID_154700105 | ||
| 0.193 | 0.075 | 0.193 | 5 Hydroxytryptamine 3E antagonist | 0.163 0.162 CID_154700105 | ||
| 0.128 | 0.011 | 0.128 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.157 | 0.041 | 0.161 | Pregnane X receptor agonist | 0.161 0.036 CID_154700105 | CID_154700105 | |
| 0.186 | 0.075 | 0.285 | Hepatoprotectant | 0.285 0.034 CID_154700105 | CID_154700105 | |
| 0.138 | 0.028 | 0.138 | Prolactin inhibitor | |||
| 0.157 | 0.048 | 0.157 | Toll-Like receptor 2 antagonist | |||
| 0.116 | 0.007 | 0.116 | Topoisomerase II beta inhibitor | |||
| 0.133 | 0.024 | 0.133 | Porphobilinogen synthase inhibitor | 0.074 0.052 CID_154700105 | ||
| 0.131 | 0.023 | 0.131 | Histidine decarboxylase inhibitor | |||
| 0.141 | 0.034 | 0.141 | AMP-activated protein kinase stimulant | |||
| 0.121 | 0.015 | 0.121 | Argininosuccinate synthase inhibitor | |||
| 0.113 | 0.007 | 0.113 | Estrogen receptor alpha agonist | |||
| 0.137 | 0.032 | 0.137 | Beta glucuronidase inhibitor | |||
| 0.189 | 0.085 | 0.189 | Insulin sensitizer | |||
| 0.111 | 0.007 | 0.111 | Glutamate (mGluR6) antagonist | |||
| 0.149 | 0.047 | 0.149 | Cathepsin H inhibitor | 0.12 0.075 CID_154700105 | ||
| 0.134 | 0.032 | 0.134 | DOPA decarboxylase inhibitor | |||
| 0.114 | 0.013 | 0.114 | Purinergic P2X1 antagonist | 0.063 0.04 CID_154700105 | ||
| 0.115 | 0.015 | 0.115 | Adrenaline uptake inhibitor | |||
| 0.107 | 0.008 | 0.107 | Progesterone antagonist | |||
| 0.179 | 0.081 | 0.179 | DNA methyltransferase I inhibitor | |||
| 0.107 | 0.011 | 0.135 | Estrogen receptor beta agonist | 0.135 0.008 CID_154700105 | CID_154700105 | |
| 0.123 | 0.027 | 0.123 | Glutamate (mGluR7) agonist | |||
| 0.121 | 0.026 | 0.121 | CYP2A6 inhibitor | |||
| 0.114 | 0.019 | 0.114 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.099 | 0.004 | 0.099 | Adenylate cyclase 1 inhibitor | |||
| 0.103 | 0.01 | 0.103 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.071 0.021 CID_154700105 | ||
| 0.105 | 0.013 | 0.129 | Androgen agonist | 0.129 0.009 CID_154700105 | CID_154700105 | |
| 0.212 | 0.119 | 0.212 | Transcription factor STAT3 inhibitor | |||
| 0.097 | 0.005 | 0.097 | Glucose-6-phosphate isomerase inhibitor | 0.063 0.016 CID_154700105 | ||
| 0.134 | 0.042 | 0.134 | Mucolytic | |||
| 0.212 | 0.121 | 0.212 | Transcription factor STAT inhibitor | |||
| 0.121 | 0.029 | 0.121 | Histamine N-methyltransferase inhibitor | |||
| 0.182 | 0.091 | 0.182 | DNA methylase inhibitor | |||
| 0.114 | 0.024 | 0.114 | Keratolytic | |||
| 0.143 | 0.054 | 0.143 | Cyclooxygenase 3 inhibitor | |||
| 0.133 | 0.044 | 0.133 | 5-Lipoxygenase inhibitor | |||
| 0.101 | 0.013 | 0.101 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.047 CID_154700105 | ||
| 0.094 | 0.007 | 0.116 | Alpha-mannosidase inhibitor | 0.116 0.005 CID_154700105 | CID_154700105 | |
| 0.23 | 0.144 | 0.511 | Antithrombotic | 0.511 0.028 CID_154700105 | CID_154700105 | |
| 0.105 | 0.021 | 0.105 | T cell inhibitor | |||
| 0.144 | 0.06 | 0.144 | Cyclooxygenase 1 inhibitor | |||
| 0.104 | 0.02 | 0.104 | Estrogen-related receptor beta agonist | |||
| 0.114 | 0.03 | 0.114 | Ornithine decarboxylase inhibitor | |||
| 0.093 | 0.01 | 0.093 | Sphingosine kinase 2 inhibitor | |||
| 0.114 | 0.031 | 0.114 | Phosphodiesterase 6D inhibitor | 0.107 0.039 CID_154700105 | ||
| 0.125 | 0.042 | 0.125 | Bronchodilator | |||
| 0.16 | 0.079 | 0.16 | Neurotensin receptor agonist | |||
| 0.09 | 0.011 | 0.09 | Glucosylceramidase inhibitor | |||
| 0.089 | 0.011 | 0.089 | Aconitate hydratase inhibitor | |||
| 0.105 | 0.027 | 0.105 | mTOR complex 2 inhibitor | |||
| 0.214 | 0.136 | 0.214 | Insulysin inhibitor | |||
| 0.094 | 0.016 | 0.094 | Alpha tubulin antagonist | |||
| 0.131 | 0.054 | 0.131 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.103 | 0.026 | 0.103 | D-Ala-D-Ala ligase inhibitor | |||
| 0.103 | 0.026 | 0.103 | Aminopeptidase I inhibitor | |||
| 0.104 | 0.028 | 0.111 | Na+ K+ transporting ATPase inhibitor | 0.111 0.022 CID_154700105 | CID_154700105 | |
| 0.084 | 0.008 | 0.108 | Mannosidase inhibitor | 0.108 0.005 CID_154700105 | CID_154700105 | |
| 0.146 | 0.07 | 0.3 | Cell wall synthesis inhibitor | 0.3 0.01 CID_154700105 | CID_154700105 | |
| 0.109 | 0.033 | 0.118 | Bile acid receptor antagonist | 0.118 0.022 CID_154700105 | CID_154700105 | |
| 0.105 | 0.029 | 0.105 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.103 | 0.028 | 0.103 | Glutamate decarboxylase inhibitor | 0.065 0.062 CID_154700105 | ||
| 0.185 | 0.11 | 0.185 | Free radical scavenger | |||
| 0.093 | 0.02 | 0.12 | Phospholipase D inhibitor | 0.12 0.006 CID_154700105 | CID_154700105 | |
| 0.122 | 0.049 | 0.122 | Expectorant | |||
| 0.119 | 0.047 | 0.119 | Carbonic anhydrase XV inhibitor | 0.103 0.063 CID_154700105 | ||
| 0.117 | 0.047 | 0.117 | Carbonic anhydrase III inhibitor | 0.117 0.046 CID_154700105 | ||
| 0.083 | 0.013 | 0.083 | Calcium channel P-type blocker | |||
| 0.084 | 0.014 | 0.084 | Sphingosine kinase inhibitor | 0.084 0.013 CID_154700105 | ||
| 0.17 | 0.1 | 0.17 | Psychostimulant | |||
| 0.167 | 0.098 | 0.167 | Non-steroidal antiinflammatory agent | |||
| 0.152 | 0.084 | 0.152 | Heat shock protein 90 alpha antagonist | |||
| 0.142 | 0.075 | 0.142 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.088 | 0.021 | 0.088 | Protein kinase C beta inhibitor | |||
| 0.148 | 0.081 | 0.148 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.09 | 0.024 | 0.09 | MAP kinase kinase 7 inhibitor | |||
| 0.157 | 0.09 | 0.157 | Catenin beta inhibitor | |||
| 0.119 | 0.053 | 0.185 | Aminopeptidase B inhibitor | 0.185 0.025 CID_154700105 | CID_154700105 | |
| 0.108 | 0.046 | 0.108 | Protein kinase C delta inhibitor | |||
| 0.127 | 0.066 | 0.127 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.082 | 0.022 | 0.082 | Exportin-1 inhibitor | |||
| 0.088 | 0.028 | 0.088 | Vanilloid 4 agonist | |||
| 0.073 | 0.014 | 0.073 | CD45 antagonist | 0.047 0.041 CID_154700105 | ||
| 0.217 | 0.159 | 0.217 | Apoptosis antagonist | |||
| 0.082 | 0.025 | 0.082 | Glutamate (mGluR7) antagonist | |||
| 0.066 | 0.009 | 0.066 | Fumarate hydratase inhibitor | |||
| 0.066 | 0.009 | 0.066 | Geranyltranstransferase inhibitor | |||
| 0.15 | 0.094 | 0.15 | Antipruritic | |||
| 0.068 | 0.013 | 0.166 | Heparanase inhibitor | 0.166 0.003 CID_154700105 | CID_154700105 | |
| 0.092 | 0.037 | 0.108 | Interferon agonist | 0.108 0.023 CID_154700105 | CID_154700105 | |
| 0.086 | 0.031 | 0.086 | GABA B receptor agonist | |||
| 0.062 | 0.009 | 0.062 | Acid-sensing ion channel blocker | |||
| 0.088 | 0.037 | 0.088 | GABA aminotransferase inhibitor | |||
| 0.065 | 0.014 | 0.065 | Thymidylate synthase inhibitor | |||
| 0.098 | 0.048 | 0.098 | Androgen antagonist | |||
| 0.055 | 0.005 | 0.055 | Ceramide glucosyltransferase inhibitor | 0.051 0.006 CID_154700105 | ||
| 0.061 | 0.011 | 0.061 | Dopamine D5 agonist | |||
| 0.256 | 0.207 | 0.369 | Cyclophilin D inhibitor | 0.369 0.109 CID_154700105 | CID_154700105 | |
| 0.126 | 0.077 | 0.207 | Nav1.2 sodium channel blocker | 0.207 0.032 CID_154700105 | CID_154700105 | |
| 0.052 | 0.005 | 0.052 | Estrogen-related receptor beta antagonist | |||
| 0.102 | 0.055 | 0.102 | Electrolyte absorption antagonist | |||
| 0.067 | 0.02 | 0.067 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.072 | 0.027 | 0.072 | Heat shock protein 90 beta antagonist | |||
| 0.058 | 0.013 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.008 CID_154700105 | CID_154700105 | |
| 0.127 | 0.082 | 0.127 | CC chemokine 6 receptor antagonist | |||
| 0.088 | 0.043 | 0.197 | Catalase inhibitor | 0.197 0.016 CID_154700105 | CID_154700105 | |
| 0.122 | 0.078 | 0.122 | Cyclooxygenase 2 inhibitor | |||
| 0.085 | 0.041 | 0.085 | Telomerase inhibitor | |||
| 0.057 | 0.012 | 0.057 | Alpha 1d adrenoreceptor agonist | |||
| 0.058 | 0.014 | 0.058 | Thymidine kinase inhibitor | 0.041 0.029 CID_154700105 | ||
| 0.113 | 0.068 | 0.113 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.05 | 0.006 | 0.05 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.062 | 0.019 | 0.062 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.055 | 0.012 | 0.055 | Sphingosine kinase 1 inhibitor | |||
| 0.069 | 0.026 | 0.069 | Ornithine carbamoyltransferase inhibitor | |||
| 0.158 | 0.114 | 0.158 | MAP kinase kinase 2 inhibitor | |||
| 0.054 | 0.01 | 0.054 | Kainate receptor agonist | |||
| 0.114 | 0.071 | 0.114 | Transcription factor STAT6 inhibitor | |||
| 0.07 | 0.028 | 0.07 | Protein kinase C eta inhibitor | |||
| 0.064 | 0.023 | 0.064 | Phosphorylase inhibitor | 0.043 0.034 CID_154700105 | ||
| 0.127 | 0.086 | 0.127 | Nav1.6 sodium channel blocker | |||
| 0.1 | 0.059 | 0.1 | Xanthine oxidase inhibitor | |||
| 0.07 | 0.03 | 0.07 | Dopamine uptake inhibitor | |||
| 0.051 | 0.012 | 0.051 | Glutamate (mGluR3) antagonist | |||
| 0.054 | 0.016 | 0.054 | GABA B receptor antagonist | |||
| 0.066 | 0.028 | 0.066 | Fatty acid synthase inhibitor | |||
| 0.063 | 0.025 | 0.063 | Pregnane X receptor antagonist | |||
| 0.076 | 0.039 | 0.464 | Selectin antagonist | 0.464 0.003 CID_154700105 | CID_154700105 | |
| 0.043 | 0.005 | 0.043 | Purinergic P2Y15 antagonist | |||
| 0.062 | 0.024 | 0.062 | Dopamine transporter inhibitor | |||
| 0.072 | 0.034 | 0.072 | MDM2 inhibitor | |||
| 0.047 | 0.01 | 0.047 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.059 | 0.022 | 0.059 | Adenosine deaminase inhibitor | 0.043 0.037 CID_154700105 | ||
| 0.1 | 0.064 | 0.1 | MAO A inhibitor | |||
| 0.134 | 0.098 | 0.134 | MAP kinase 3 inhibitor | |||
| 0.107 | 0.071 | 0.107 | Monophenol monooxygenase inhibitor | |||
| 0.047 | 0.011 | 0.047 | Vanilloid 3 antagonist | |||
| 0.049 | 0.014 | 0.056 | Phosphoglycerate kinase inhibitor | 0.056 0.012 CID_154700105 | CID_154700105 | |
| 0.064 | 0.029 | 0.064 | Ryanodine receptor antagonist | |||
| 0.07 | 0.036 | 0.425 | HIV-1 integrase (Strand Transfer) inhibitor | 0.425 0.004 CID_154700105 | CID_154700105 | |
| 0.042 | 0.008 | 0.042 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.082 | 0.048 | 0.082 | Macrophage migration inhibitory factor inhibitor | |||
| 0.069 | 0.036 | 0.084 | Interferon inducer | 0.084 0.021 CID_154700105 | CID_154700105 | |
| 0.061 | 0.027 | 0.061 | Leukotriene B4 antagonist | 0.061 0.027 CID_154700105 | ||
| 0.044 | 0.01 | 0.044 | ATP citrate lysase inhibitor | |||
| 0.038 | 0.005 | 0.038 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.014 CID_154700105 | ||
| 0.04 | 0.007 | 0.04 | Adenosine kinase inhibitor | |||
| 0.038 | 0.005 | 0.038 | Hedgehog signaling activator | |||
| 0.067 | 0.035 | 0.067 | Transcription factor RelA inhibitor | |||
| 0.129 | 0.097 | 0.129 | Acetylcholine M1 receptor antagonist | |||
| 0.067 | 0.036 | 0.067 | Prostaglandin F2 alpha antagonist | |||
| 0.055 | 0.024 | 0.055 | Aldosterone antagonist | |||
| 0.039 | 0.009 | 0.039 | Prostaglandin EP2 agonist | |||
| 0.05 | 0.02 | 0.05 | Liver X receptor alpha agonist | |||
| 0.083 | 0.053 | 0.083 | Adrenaline agonist | |||
| 0.129 | 0.099 | 0.129 | Insulin secretagoues | |||
| 0.063 | 0.033 | 0.063 | Ca(v)3.2 blocker | |||
| 0.158 | 0.129 | 0.158 | Histone acetyltransferase inhibitor | |||
| 0.037 | 0.008 | 0.037 | Sodium/glucose cotransporter inhibitor | |||
| 0.033 | 0.004 | 0.033 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.04 | 0.012 | 0.04 | Uridine phosphorylase inhibitor | |||
| 0.061 | 0.033 | 0.061 | Lipocortins synthesis agonist | |||
| 0.055 | 0.026 | 0.055 | Squalene epoxidase inhibitor | |||
| 0.031 | 0.004 | 0.031 | Antibiotic Anthracycline-like | |||
| 0.058 | 0.031 | 0.058 | DNA helicase inhibitor | |||
| 0.044 | 0.017 | 0.044 | Glutamate (mGluR8) agonist | |||
| 0.03 | 0.003 | 0.03 | Thromboxane A2 agonist | |||
| 0.082 | 0.055 | 0.084 | Carbonic anhydrase VI inhibitor | 0.084 0.053 CID_154700105 | CID_154700105 | |
| 0.051 | 0.024 | 0.051 | NMDA receptor subunit 3B antagonist | |||
| 0.137 | 0.111 | 0.137 | Interleukin 6 antagonist | |||
| 0.104 | 0.078 | 0.206 | Acetylcholine release stimulant | 0.206 0.004 CID_154700105 | CID_154700105 | |
| 0.037 | 0.011 | 0.319 | NMDA 2D receptor antagonist | 0.319 0.001 CID_154700105 | CID_154700105 | |
| 0.046 | 0.02 | 0.046 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.066 | 0.041 | 0.066 | Beta 3 adrenoreceptor antagonist | |||
| 0.054 | 0.03 | 0.054 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.042 | 0.018 | 0.042 | Delayed rectifier potassium channel blocker | |||
| 0.047 | 0.023 | 0.047 | Nerve growth factor antagonist | |||
| 0.144 | 0.12 | 0.144 | Pyruvate kinase inhibitor | |||
| 0.115 | 0.093 | 0.115 | Interleukin 4 antagonist | |||
| 0.044 | 0.022 | 0.044 | NMDA receptor subunit 3A antagonist | |||
| 0.059 | 0.04 | 0.059 | Botulinum neurotoxin type A inhibitor | |||
| 0.08 | 0.061 | 0.08 | Thioredoxin reductase inhibitor | |||
| 0.046 | 0.027 | 0.046 | AICAR transformylase inhibitor | |||
| 0.062 | 0.043 | 0.133 | NMDA 2C receptor antagonist | 0.133 0.009 CID_154700105 | CID_154700105 | |
| 0.06 | 0.041 | 0.06 | Aromatase inhibitor | 0.057 0.043 CID_154700105 | ||
| 0.042 | 0.024 | 0.042 | GABA uptake inhibitor | |||
| 0.035 | 0.017 | 0.035 | Prostaglandin agonist | |||
| 0.029 | 0.011 | 0.029 | Vanilloid 2 agonist | 0.025 0.018 CID_154700105 | ||
| 0.125 | 0.107 | 0.447 | Protein-tyrosine phosphatase inhibitor | 0.447 0.006 CID_154700105 | CID_154700105 | |
| 0.055 | 0.038 | 0.055 | Immunoglobulin Fc receptor antagonist | |||
| 0.139 | 0.122 | 0.139 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.104 | 0.087 | 0.104 | Interleukin 8 antagonist | |||
| 0.103 | 0.087 | 0.103 | Acetylcholine muscarinic antagonist | |||
| 0.026 | 0.009 | 0.026 | Isoleucine-tRNA ligase inhibitor | |||
| 0.022 | 0.006 | 0.022 | Telomerase stimulant | |||
| 0.027 | 0.011 | 0.027 | Prostaglandin F2 alpha agonist | |||
| 0.086 | 0.07 | 0.086 | Thioredoxin inhibitor | |||
| 0.037 | 0.022 | 0.037 | Retinoid X alpha receptor agonist | |||
| 0.061 | 0.046 | 0.061 | Beta 2 adrenoreceptor agonist | |||
| 0.117 | 0.102 | 0.117 | Cyclooxygenase inhibitor | |||
| 0.118 | 0.103 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.084 | 0.069 | 0.084 | Potassium channel activator | |||
| 0.038 | 0.024 | 0.038 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.039 | 0.025 | 0.039 | 5-Alpha-reductase inhibitor | |||
| 0.115 | 0.101 | 0.115 | Vanilloid 1 agonist | |||
| 0.041 | 0.028 | 0.041 | Plasmepsin II inhibitor | |||
| 0.046 | 0.033 | 0.046 | Potassium channel Kv1.3 blocker | |||
| 0.049 | 0.037 | 0.049 | Beta 2 adrenoreceptor antagonist | |||
| 0.016 | 0.004 | 0.016 | Thromboxane agonist | |||
| 0.027 | 0.016 | 0.027 | Thymidine phosphorylase inhibitor | |||
| 0.02 | 0.009 | 0.02 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.034 | 0.023 | 0.034 | Tubulin agonist | |||
| 0.024 | 0.015 | 0.024 | Prostaglandin E2 agonist | |||
| 0.071 | 0.062 | 0.071 | Potassium channel (Tandem pore domain) blocker | |||
| 0.039 | 0.03 | 0.039 | CF transmembrane conductance regulator antagonist | |||
| 0.073 | 0.065 | 0.073 | Histamine H1 receptor antagonist | |||
| 0.07 | 0.062 | 0.07 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.029 | 0.021 | 0.029 | RNA-directed RNA polymerase stimulant | |||
| 0.093 | 0.085 | 0.093 | 5 Hydroxytryptamine 3A agonist | |||
| 0.021 | 0.013 | 0.021 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.018 | 0.011 | 0.018 | Alpha 2a adrenoreceptor agonist | |||
| 0.016 | 0.009 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 CID_154700105 | ||
| 0.095 | 0.088 | 0.095 | Anesthetic local | |||
| 0.061 | 0.054 | 0.061 | Beta adrenoreceptor antagonist | |||
| 0.025 | 0.018 | 0.025 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.044 | 0.038 | 0.044 | Beta adrenoreceptor agonist | |||
| 0.032 | 0.027 | 0.032 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.058 | 0.053 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.034 | 0.029 | 0.034 | Antibiotic Aminoglycoside-like | |||
| 0.053 | 0.048 | 0.053 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.041 | 0.036 | 0.041 | Heme oxygenase inhibitor | |||
| 0.047 | 0.042 | 0.047 | Potassium channel (Inward rectifier) activator | |||
| 0.067 | 0.062 | 0.201 | Carbonic anhydrase XIII inhibitor | 0.201 0.014 CID_154700105 | CID_154700105 | |
| 0.027 | 0.022 | 0.027 | Liver X receptor beta antagonist | |||
| 0.031 | 0.026 | 0.031 | Glutamate (mGluR3) agonist | |||
| 0.032 | 0.027 | 0.032 | Retinoid X receptor agonist | |||
| 0.045 | 0.041 | 0.045 | Potassium channel (ATP-sensitive) activator | |||
| 0.032 | 0.027 | 0.032 | Free fatty acid receptor 1 antagonist | |||
| 0.032 | 0.028 | 0.032 | HMG CoA reductase inhibitor | |||
| 0.082 | 0.078 | 0.082 | Protein kinase C mu inhibitor | |||
| 0.092 | 0.087 | 0.238 | Protein-tyrosine phosphatase 1B inhibitor | 0.238 0.019 CID_154700105 | CID_154700105 | |
| 0.029 | 0.025 | 0.047 | Cholesterol ester transfer protein antagonist | 0.047 0.009 CID_154700105 | CID_154700105 | |
| 0.058 | 0.054 | 0.058 | Leukotriene antagonist | |||
| 0.01 | 0.007 | 0.01 | Purinergic P2Y2 agonist | |||
| 0.17 | 0.166 | 0.17 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.056 | 0.052 | 0.386 | HIV-1 integrase (3'-Processing) inhibitor | 0.386 0.004 CID_154700105 | CID_154700105 | |
| 0.034 | 0.031 | 0.039 | Farnesoid X receptor agonist | 0.039 0.025 CID_154700105 | CID_154700105 | |
| 0.178 | 0.175 | 0.178 | 12-Lipoxygenase inhibitor | |||
| 0.009 | 0.007 | 0.009 | Progesterone receptor A antagonist | |||
| 0.016 | 0.013 | 0.016 | Ileal bile acid transport inhibitor | |||
| 0.142 | 0.139 | 0.142 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.053 | 0.051 | 0.053 | Acetylcholine M3 receptor antagonist | |||
| 0.015 | 0.013 | 0.015 | Adenosine A2 receptor agonist | |||
| 0.045 | 0.043 | 0.045 | Cytokine production stimulant | |||
| 0.034 | 0.032 | 0.034 | Glutamate (mGluR group II) antagonist | |||
| 0.019 | 0.017 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.014 | 0.012 | 0.014 | Adenosine A2a receptor agonist | |||
| 0.021 | 0.02 | 0.021 | Adenosine A1 receptor agonist | |||
| 0.02 | 0.018 | 0.02 | Leukotriene B4 receptor 2 antagonist | |||
| 0.033 | 0.032 | 0.033 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.027 | 0.026 | 0.027 | Purinergic P2Y14 antagonist | |||
| 0.013 | 0.022 | 0.03 | Sodium/hydrogen exchanger inhibitor | 0.03 0.005 CID_154700105 | CID_154700105 | |
| 0.201 | 0.213 | 0.255 | 15-Lipoxygenase inhibitor | 0.255 0.16 CID_154700105 | CID_154700105 | |
| 0.033 | 0.046 | 0.043 | Purinergic P2Y antagonist | 0.043 0.033 CID_154700105 | CID_154700105 | |
| 0.053 | 0.069 | 0.086 | Protease 3C (Human rhinovirus) inhibitor | 0.086 0.023 CID_154700105 | CID_154700105 | |
| 0.106 | 0.124 | 0.38 | Diuretic | 0.38 0.014 CID_154700105 | CID_154700105 | |
| 0.036 | 0.059 | 0.046 | Aldose reductase inhibitor | 0.046 0.043 CID_154700105 | CID_154700105 | |
| 0.036 | 0.061 | 0.124 | Carbonic anhydrase VB inhibitor | 0.124 0.012 CID_154700105 | CID_154700105 | |
| 0.014 | 0.039 | 0.056 | Glutamate (mGluR1a) agonist | 0.056 0.005 CID_154700105 | CID_154700105 | |
| 0.057 | 0.085 | 0.253 | CDC25A inhibitor | 0.253 0.004 CID_154700105 | CID_154700105 | |
| 0.024 | 0.055 | 0.07 | Purinergic P2Y2 antagonist | 0.07 0.006 CID_154700105 | CID_154700105 | |
| 0.049 | 0.082 | 0.119 | Carbonic anhydrase VA inhibitor | 0.119 0.018 CID_154700105 | CID_154700105 | |
| 0.044 | 0.08 | 0.171 | Carbonic anhydrase V inhibitor | 0.171 0.01 CID_154700105 | CID_154700105 | |
| 0.084 | 0.122 | 0.11 | Nav1.5 sodium channel blocker | 0.11 0.068 CID_154700105 | CID_154700105 | |
| 0.123 | 0.164 | 0.15 | Anticonvulsant | 0.15 0.129 CID_154700105 | CID_154700105 | |
| 0.012 | 0.055 | 0.024 | Kynurenine 3 monooxygenase inhibitor | 0.024 0.021 CID_154700105 | CID_154700105 | |
| 0.094 | 0.139 | 0.137 | Antibacterial (Helicobacter pylori) | 0.137 0.059 CID_154700105 | CID_154700105 | |
| 0.025 | 0.07 | 0.054 | NMDA 2A receptor antagonist | 0.054 0.034 CID_154700105 | CID_154700105 | |
| 0.106 | 0.151 | 0.374 | Hemostatic | 0.374 0.009 CID_154700105 | CID_154700105 | |
| 0.052 | 0.098 | 0.128 | HIV-1 integrase inhibitor | 0.128 0.013 CID_154700105 | CID_154700105 | |
| 0.044 | 0.091 | 0.141 | Adenine nucleotide translocase inhibitor | 0.141 0.003 CID_154700105 | CID_154700105 | |
| 0.017 | 0.069 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.038 0.004 CID_154700105 | CID_154700105 | |
| 0.066 | 0.119 | 0.11 | Gastric antisecretory | 0.11 0.054 CID_154700105 | CID_154700105 | |
| 0.041 | 0.1 | 0.072 | NMDA receptor agonist | 0.072 0.035 CID_154700105 | CID_154700105 | |
| 0.015 | 0.076 | 0.027 | Glutamate (mGluR1) agonist | 0.027 0.013 CID_154700105 | CID_154700105 | |
| 0.23 | 0.291 | 0.731 | Antiinflammatory | 0.731 0.025 CID_154700105 | CID_154700105 | |
| 0.029 | 0.1 | 0.05 | GABA receptor antagonist | 0.05 0.044 CID_154700105 | CID_154700105 | |
| 0.027 | 0.101 | 0.094 | Carbonic anhydrase inhibitor | 0.094 0.029 CID_154700105 | CID_154700105 | |
| 0.078 | 0.161 | 0.116 | Alkaline phosphatase inhibitor | 0.116 0.091 CID_154700105 | CID_154700105 | |
| 0.04 | 0.125 | 0.109 | Cathepsin G inhibitor | 0.109 0.03 CID_154700105 | CID_154700105 | |
| 0.006 | 0.091 | 0.092 | Estrone sulfatase inhibitor | 0.092 0.005 CID_154700105 | CID_154700105 | |
| 0.009 | 0.105 | 0.022 | Dopamine D1 agonist | 0.022 0.017 CID_154700105 | CID_154700105 | |
| 0.08 | 0.185 | 0.839 | Angiogenesis stimulant | 0.839 0.003 CID_154700105 | CID_154700105 | |
| 0.049 | 0.162 | 0.356 | Cell adhesion molecule inhibitor | 0.356 0.005 CID_154700105 | CID_154700105 | |
| 0.017 | 0.129 | 0.064 | Toll-Like receptor 4 agonist | 0.064 0.003 CID_154700105 | CID_154700105 | |
| 0.064 | 0.194 | 0.113 | Cytokine production inhibitor | 0.113 0.097 CID_154700105 | CID_154700105 | |
| 0.134 | 0.268 | 0.281 | Immunomodulator | 0.281 0.093 CID_154700105 | CID_154700105 | |
| 0.014 | 0.187 | 0.058 | Leukocyte elastase inhibitor | 0.058 0.019 CID_154700105 | CID_154700105 | |
| 0.061 | 0.235 | 0.241 | Cell adhesion inhibitor | 0.241 0.016 CID_154700105 | CID_154700105 | |
| 0.024 | 0.2 | 0.136 | Neuraminidase (influenza) inhibitor | 0.136 0.009 CID_154700105 | CID_154700105 | |
| 0.048 | 0.245 | 0.242 | Thrombolytic | 0.242 0.036 CID_154700105 | CID_154700105 | |
| 0.014 | 0.218 | 0.085 | Neuraminidase inhibitor | 0.085 0.022 CID_154700105 | CID_154700105 | |
| 0.008 | 0.235 | 0.069 | Factor Xa inhibitor | 0.069 0.021 CID_154700105 | CID_154700105 | |
| 0.073 | 0.309 | 0.259 | Tumour necrosis factor alpha release inhibitor | 0.259 0.071 CID_154700105 | CID_154700105 | |
| 0.063 | 0.316 | 0.166 | Platelet antagonist | 0.166 0.129 CID_154700105 | CID_154700105 | |
| 0.005 | 0.26 | 0.049 | Dopamine D2 agonist | 0.049 0.027 CID_154700105 | CID_154700105 | |
| 0.057 | 0.344 | 0.376 | Platelet adhesion inhibitor | 0.376 0.014 CID_154700105 | CID_154700105 | |
| 0.012 | 0.347 | 0.867 | Cholecystokinin B agonist | 0.867 0.001 CID_154700105 | CID_154700105 | |
| 0.019 | 0.364 | 0.205 | Factor IXa inhibitor | 0.205 0.003 CID_154700105 | CID_154700105 | |
| 0.033 | 0.412 | 0.503 | Dual specificity phosphatase 3 inhibitor | 0.503 0.007 CID_154700105 | CID_154700105 | |
| 0.031 | 0.443 | 0.484 | Dual specificity phosphatase inhibitor | 0.484 0.007 CID_154700105 | CID_154700105 | |
| 0.01 | 0.526 | 0.084 | Fibroblast growth factor 1 antagonist | 0.084 0.071 CID_154700105 | CID_154700105 | |
| 0.024 | 0.541 | 0.15 | Nav1.4 sodium channel blocker | 0.15 0.034 CID_154700105 | CID_154700105 | |
| 0.034 | 0.593 | 0.782 | Angiogenesis inhibitor | 0.782 0.005 CID_154700105 | CID_154700105 | |
| 0.003 | 0.616 | 0.837 | Cholecystokinin agonist | 0.837 0.001 CID_154700105 | CID_154700105 | |
| 0.003 | 0.621 | 0.815 | Cholecystokinin A agonist | 0.815 0.001 CID_154700105 | CID_154700105 | |
| 0.003 | 0.648 | 0.369 | Cholecystokinin B antagonist | 0.369 0.003 CID_154700105 | CID_154700105 | |
| 0.003 | 0.707 | 0.444 | Cholecystokinin A antagonist | 0.444 0.003 CID_154700105 | CID_154700105 | |
| 0.009 | 0.715 | 0.775 | Anticoagulant | 0.775 0.004 CID_154700105 | CID_154700105 | |
| 0.003 | 0.733 | 0.358 | Cholecystokinin antagonist | 0.358 0.004 CID_154700105 | CID_154700105 | |
| 0.009 | 0.801 | 0.239 | Multidrug resistance-associated protein 1 inhibitor | 0.239 0.005 CID_154700105 | CID_154700105 | |
| 0.004 | 0.918 | 0.087 | Elastase inhibitor | 0.087 0.013 CID_154700105 | CID_154700105 | |
| 0.004 | 0.943 | 0.093 | Thrombin inhibitor | 0.093 0.03 CID_154700105 | CID_154700105 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |